G

GMED

GMED

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
GMED Live QuoteReal-time
$68.60
$10.08(-12.81%)1M
Day Range$68.25 – $70.85
Open$70.27
Previous Close$70.53
Volume1.28M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$9.34B
P/E Ratio (TTM)17.4
Forward P/E13.4
EPS (TTM)$4.06
Price to Book1.9
Dividend Yield0.65%
Beta (Volatility)0.95
IndustryMEDICAL DEVICES
52-Week RangeCurrent: $68.60 (1%)
Low: $68.25High: $101.40
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$93.43-37.7% upside

Insider Buys

0

$0

Insider Sales

22

$41.06M

Total Volume

$41.06M

41 transactions

Net Activity

$41.06M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
S
1

Scavilla Daniel T

Pres, CEO

0 buys2 sells

$15.85M total

D
2

Davidar David D

Dir

0 buys3 sells

$7.57M total

Z
3

Zarrilli Stephen T

Dir

0 buys2 sells

$4.28M total

H
4

Huller Kelly

EVP, GC, Corporate Secretary

0 buys5 sells

$4.06M total

T
5

Tobin James R

Dir

0 buys1 sells

$2.24M total

Trading History
GMED insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 15, 2026

2 months ago

Tobin James R

Dir

Director
Sell30.0K$74.58$2.24M

Sep 15, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-30000.00$0

Aug 18, 2026

3 months ago

Zarrilli Stephen T

Dir

Director
Sell25.0K$87.04$2.18M

Aug 18, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-25000.00$0

Jun 5, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell676.1K$-25000.00$0

Jun 5, 2026

5 months ago

Davidar David D

Dir

Director
Sell25.0K$80.76$2.02M

Feb 25, 2026

8 months ago

Huller Kelly

EVP, GC, Corporate Secretary

EVP
Sell20.0K$94.50$1.89M

Feb 25, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-20000.00$0

Feb 12, 2026

9 months ago

Huller Kelly

EVP, GC, Corporate Secretary

EVP
Sell10.0K$87.67$877K

Feb 12, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-10000.00$0

Jan 8, 2026

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-3594.00$0

Jan 8, 2026

10 months ago

Kline Kyle

SVP, CFO

CFO
Sell3.6K$101.10$363K

Jan 8, 2026

10 months ago

Norwalk Leslie V

Dir

Director
Sell2.0K$101.10$202K

Dec 12, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell12.4K$-4000.00$0

Dec 12, 2025

11 months ago

Norwalk Leslie V

Dir

Director
Sell4.0K$88.85$355K

Dec 1, 2025

11 months ago

Kline Kyle

SVP, CFO

CFO
Sell18.5K$90.00$1.67M

Dec 1, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-18542.00$0

Nov 25, 2025

12 months ago

Huller Kelly

SVP, GC, Corporate Secretary

SVP
Sell7.5K$90.00$675K

Nov 25, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-7500.00$0

Nov 12, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell682.2K$-25000.00$0

Nov 11, 2025

12 months ago

Zarrilli Stephen T

Dir

Director
Sell25.0K$84.29$2.11M

Nov 11, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-25000.00$0

Nov 12, 2025

12 months ago

Davidar David D

Dir

Director
Sell25.0K$86.00$2.15M

Nov 7, 2025

12 months ago

Rhoads Ann D

Dir

Director
Sell10.0K$81.80$818K

Nov 7, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell15.4K$-10000.00$0

Sep 15, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell25.4K$-10000.00$0

Sep 15, 2025

14 months ago

Rhoads Ann D

Dir

Director
Sell10.0K$58.46$585K

Feb 28, 2025

21 months ago

Rhoads Ann D

Dir

Director
Sell7.5K$78.68$590K

Feb 28, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell35.4K$-7500.00$0

Jan 10, 2025

22 months ago

Pfeil Keith W

COO, CFO

CFO
Sell14.2K$88.29$1.25M

Jan 10, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-14167.00$0

Dec 2, 2024

23 months ago

Huller Kelly

SVP, GC, Corporate Secretary

SVP
Sell2.5K$87.00$218K

Dec 2, 2024

23 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-2500.00$0

Nov 21, 2024

24 months ago

Davidar David D

Dir

Director
Sell40.0K$85.00$3.40M

Nov 21, 2024

24 months ago

Scavilla Daniel T

Pres, CEO

CEO
Sell130.0K$85.00$11.05M

Nov 21, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell682.2K$-40000.00$0

Nov 21, 2024

24 months ago

Lemaitre Dan

Dir

Director
Sell14.4K$85.00$1.22M

Nov 6, 2024

24 months ago

Huller Kelly

SVP, GC, Corporate Secretary

SVP
Sell5.0K$81.01$405K

Nov 6, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-60000.00$0

Nov 6, 2024

24 months ago

Scavilla Daniel T

Pres, CEO

CEO
Sell60.0K$80.02$4.80M

Oct 16, 2024

25 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-7500.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
GMED Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.2%
Total Industry Activity$16.53B

GMED has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for GMED

Over the last 90 days, corporate insiders at GMED (GMED) engaged in a total of 41 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 22 were sales. The total volume of insider trading reached $41.06M.

The net insider activity for GMED shows a net selling bias of $41.06M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Scavilla Daniel T (Pres, CEO), who traded 130.0K shares valued at $11.05M on Nov 21, 2024.

Live Market News & Developments
Aggregated real-time headlines for GMED (GMED)
6 updates

Globus Medical, Inc. (GMED) stock price, news, quote and history

Yahoo Finance AustraliaYesterday

Is Globus Medical (GMED) Still Undervalued Following Its Jefferies London Healthcare Conference Update?

Yahoo! Finance Canada7h ago

Globus Medical (NYSE:GMED) Stock Forecast & Analyst Predictions

Simply Wall St11d ago

Globus Medical (GMED) Stock Gets Fair Value Trim After Mixed Analyst Revisions

Yahoo Finance10d ago

Globus Medical, Inc. (GMED) Stock Forecasts

Yahoo! Finance Canada3d ago

Globus Medical, Inc. (GMED) Stock Forecasts

Yahoo Finance3d ago

FAQs About GMED Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for GMED.

Based on SEC Form 4 disclosures, the Insider Confidence Score for GMED is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 22 sales by company executives over the last 90 days.

The CEO Conviction Index for GMED is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.